Stock Research: Lifecore Biomedical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Lifecore Biomedical

NasdaqGS:LNDC US5147661046
23
  • Value
    6
  • Growth
    97
  • Safety
    Safety
    20
  • Combined
    25
  • Sentiment
    29
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Lifecore Biomedical, Inc. is a CDMO that develops, manufactures, and sells products for biomaterials markets. The company operates in the biomaterials and pharmaceutical industries. It offers products globally. In the last fiscal year, the company had a market cap of $288 million, profits of $42 million, and revenue of $128 million, with 524 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock Lifecore Biomedical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Lifecore Biomedical. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 97% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 20 means that the share price of Lifecore Biomedical is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 80% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 6, which means that the company has a riskier financing structure than 94% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 29, indicating professional investors are more pessimistic about the stock than for 71% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
20 22 8 37
Growth
97 37 73 1
Safety
Safety
6 65 35 26
Sentiment
29 13 14 60
360° View
360° View
23 8 4 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
67 35 85 89
Opinions Change
50 50 50 50
Pro Holdings
n/a 8 8 63
Market Pulse
20 8 1 6
Sentiment
29 13 14 60
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
20 22 8 37
Growth
97 37 73 1
Safety Safety
6 65 35 26
Combined
25 26 23 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
3 3 1 16
Price vs. Earnings (P/E)
34 31 47 49
Price vs. Book (P/B)
17 29 15 60
Dividend Yield
1 1 1 1
Value
20 22 8 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 86 92 1
Profit Growth
90 1 82 8
Capital Growth
81 70 35 26
Stock Returns
95 21 39 43
Growth
97 37 73 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
6 9 6 24
Refinancing
63 76 84 59
Liquidity
1 77 18 21
Safety Safety
6 65 35 26

Similar Stocks

Discover high‑ranked alternatives to Lifecore Biomedical and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.